Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Molecular Therapy. Methods & Clinical Development
|
September 12, 2022
Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I
Cristina Mesa-Núñez, Carlos Damián, María Fernández-García, et al.
The New England Journal of Medicine
|
November 18, 2024
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
Barry Greenberg, Matthew Taylor, Eric Adler, et al.
Journal of Neuropathology and Experimental Neurology
|
February 14, 2026
Dysembryoplastic neuroepithelial tumor: Malignant transformation following radiation
Yi Zhu, Cristiane M Ida, Jonathan D Schwartz, et al.
Frontiers in Pediatrics
|
August 27, 2025
Case Report: Eltrombopag in mosaic and gene therapy-treated patients with Fanconi anemia
Josune Zubicaray, June Iriondo, Elena Sebastián, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 17, 2014
A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma
Richard D Carvajal, Michael K Wong, John A Thompson, et al.
American Journal of Hematology
|
January 6, 2022
Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD
Jonathan D Schwartz, Wilma Barcellini, Rachel F Grace, et al.
Pediatric Blood & Cancer
|
October 19, 2023
Busulfan and subsequent malignancy: An evidence-based risk assessment
Janel R Long-Boyle, Donald B Kohn, Ami J Shah, et al.
Cancer
|
March 1, 2014
A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy
Jorge A Garcia, Gary R Hudes, Toni K Choueiri, et al.
Cancer Investigation
|
December 8, 2004
Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu
Howard Safran, David Iannitti, Ramesh Ramanathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2008
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
Abby B Siegel, Emil I Cohen, Allyson Ocean, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Molecular Therapy. Methods & Clinical Development
|
September 12, 2022
Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I
Cristina Mesa-Núñez, Carlos Damián, María Fernández-García, et al.
The New England Journal of Medicine
|
November 18, 2024
Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
Barry Greenberg, Matthew Taylor, Eric Adler, et al.
Journal of Neuropathology and Experimental Neurology
|
February 14, 2026
Dysembryoplastic neuroepithelial tumor: Malignant transformation following radiation
Yi Zhu, Cristiane M Ida, Jonathan D Schwartz, et al.
Frontiers in Pediatrics
|
August 27, 2025
Case Report: Eltrombopag in mosaic and gene therapy-treated patients with Fanconi anemia
Josune Zubicaray, June Iriondo, Elena Sebastián, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 17, 2014
A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma
Richard D Carvajal, Michael K Wong, John A Thompson, et al.
American Journal of Hematology
|
January 6, 2022
Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD
Jonathan D Schwartz, Wilma Barcellini, Rachel F Grace, et al.
Pediatric Blood & Cancer
|
October 19, 2023
Busulfan and subsequent malignancy: An evidence-based risk assessment
Janel R Long-Boyle, Donald B Kohn, Ami J Shah, et al.
Cancer
|
March 1, 2014
A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy
Jorge A Garcia, Gary R Hudes, Toni K Choueiri, et al.
Cancer Investigation
|
December 8, 2004
Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu
Howard Safran, David Iannitti, Ramesh Ramanathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2008
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
Abby B Siegel, Emil I Cohen, Allyson Ocean, et al.
Page
of 6